TransMedics Group (TMDX) is scheduled to report third-quarter 2024 results on Oct. 28, after market close.In the last reported quarter, the company’s adjusted earnings per share of 35 cents surpassed the Zacks Consensus Estimate by 66.7%. Earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 287.5%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.TMDX’s Q3 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $114.2 million, imp ...